• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Adarotene Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754479

Adarotene is an effective apoptosis inducer. It surprisingly produces DNA damage and exhibites a potent antiproliferative activity on a large panel of human tumor cells. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Adarotene, Inhibitor
Full Product Name
Adarotene
Product Synonym Names
ST1926
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
374.47
Solubility
DMSO: 25mg/mL (66.76mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C25H26O3
SMILES
O=C(O)/C=C/C1=CC=C(C2=CC=C(O)C(C3(C4)CC5CC4CC(C5)C3)=C2)C=C1
CAS Number
496868-77-0
Target & IC50
Others
In Vitro
Adarotene (30, 40mg/kg, p.o.) results in a significant and dose-dependent increase in the life span of NB4-bearing SCID mice without overt toxicity[2]. Adarotene (15, 20mg/kg, p.o.) causes a significant tumor growth inhibition in a human ovarian carcinoma, A2780/DX, and in a human melanoma, MeWo, growing in nude mice[1].

Structure of Adarotene, inhibitor

Adarotene Inhibitor – Cat# MBS5754479

Product References and Citations for Adarotene, inhibitor

Cincinelli R, et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity. J Med Chem. 2003 Mar 13;46(6):909-12.
Cincinelli R, et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity. J Med Chem. 2003 Mar 13;46(6):909-12.
Garattini E, et al. ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
Garattini E, et al. ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.

Other Notes

Small volumes of Adarotene, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Adarotene purchase

MBS5754479 is an inhibitor targeting Adarotene.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000